Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Bronchoscopes used to Study the Inner Airways of Lungs : Industrial Forecasting and Analysis

    Oct 10, 2016, 04:05 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Oct 10, 2016 - Bronchoscopes belong to a type of endoscopy medical devices used to study the inner airways of the lungs
    Full story
  • Food & Environmental Allergies: Test, Treatment & Prevention – OC Wellness Physicians

    Oct 8, 2016, 00:23 AM by Michael Croft
    WESTMINSTER, CA, UNITED STATES - Oct 7, 2016 - Every day, humans make contact with food and the environment on multiple occasions. Certain types of food, as well as natural and synthetic parts of the environment, can cause great harm to the body’s immune system
    Full story
  • Panasas, HGST Offer iRODS Solution

    Oct 7, 2016, 13:35 PM by Michael Croft
    Bio-IT World Brief | Yesterday Panasas and HGST announced a solution using iRODS to link the Panasas ActiveStor storage system with HGST’s object storage Active Archive System.
    Full story
  • Bill Gates Succumbs to Moonshot Madness

    Oct 7, 2016, 10:52 AM by Michael Croft
    Omics! Omics! Blog | Keith Robison comments on what he calls a misguided call for a moonshot in human disease from Bill Gates. Gates recently laid out four goals for disease prevention he believes can be attained in the next decade.
    Full story
  • How to Get Relief from Chronic pain with Nerve Block Therapy?

    Oct 6, 2016, 16:20 PM by Michael Croft
    WESTMINSTER, CA, UNITED STATES - Oct 7, 2016 - Chronic pain is a debilitating condition that is difficult to treat. Many people that suffer from chronic pain are not able to complete daily tasks to maintain their lifestyle simply because the pain is too great
    Full story
  • American Laboratory Trading (ALT) Selected into Agilent Technologies’ Channel Partnership Program

    Oct 6, 2016, 12:10 PM by Michael Croft
    EAST LYME, CT, USA - Oct 6, 2016 - American Laboratory Trading Inc. (ALT), the largest provider of premium refurbished lab equipment in North America, has been selected by Agilent Technologies to be a part of its Channel Partnership Program
    Full story
  • Biotech Billionaire Backs Company Geared At Ending Food Allergies

    Oct 6, 2016, 11:04 AM by Michael Croft
    Forbes | Before Brands, a business that wants to prevent food allergies before they even start, launched this morning with $13.1 million in funding from backers including Gurnet Point, run by biotech billionaire Ernesto Bertarelli.
    Full story
  • Dramatic Twists Could Upend Patent Battle Over CRISPR Genome-Editing Method

    Oct 6, 2016, 10:16 AM by Michael Croft
    Science | AAAS | Unusual maneuver in CRISPR patent battle could divide spoils, but French company Cellectis also lays claim.
    Full story
  • Health Insurance Companies are Utilizing Cloud Computing to Improve Market Penetration Strategies

    Oct 6, 2016, 07:34 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Oct 6, 2016 - The concept of health insurance, in general, is objectively simple whereinan individual or organization purchase services or plans to avoid their risk in event of un-avoidable health conditions
    Full story
  • IOMICS Announces Advanced Software to Identify Chemical Hazards

    Oct 5, 2016, 13:57 PM by Michael Croft
    CAMBRIDGE, MA - Oct 5, 2016 -  IOMICS today announced the release of its first vertical product, FUSION STS, a new class of chemical analytics that will allow scientists and chemical engineers to rapidly build and deploy in silico HTS systems that can be used stand-alone or to augment in vitro screening initiatives
    Full story
  • Sekisui XenoTech Introduces Lysosomal Test Systems for Biopharmaceutical Development

    Oct 5, 2016, 09:56 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - Oct 5, 2016 - Sekisui XenoTech now offers hepatic human lysosomes and rat tritosomes as standard test systems. These products contain high concentrations of lysosomal degradative enzymes and constitute advantageous test systems for analysis of catabolism and/or activation for targeted biopharmaceuticals that enter cells through the endosomal-lysosomal pathway
    Full story
  • Rumors, Expectations Surround Apple Expansion Into Health Care

    Oct 5, 2016, 09:15 AM by Michael Croft
    POLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.
    Full story
  • The International Biomedical Research Alliance Appoints Life Sciences Patent Lawyer to its Board

    Oct 5, 2016, 08:38 AM by Michael Croft
    BETHESDA, MD - Oct 5, 2016 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Jeffrey I
    Full story
  • Gene Editing Takes the Stage at Discovery on Target 2016

    Oct 5, 2016, 07:00 AM by Michael Croft

    Bio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.

    Full story
  • Recipharm launches serialisation showcase line

    Oct 5, 2016, 04:22 AM by Michael Croft
    FONTAINE, FRANCE - Oct 3, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has launched a showcase line for serialisation, offering pharmaceutical companies the chance to view and trial its solution to the new European and US regulations
    Full story
  • Azure is becoming the first AI supercomputer says Microsoft

    Oct 4, 2016, 15:34 PM by Michael Croft
    ZDNet | Microsoft's CEO on how its cloud computing service is evolving.
    Full story
  • Anti-Aging Through Regenerative Medicine

    Oct 4, 2016, 14:17 PM by Michael Croft
    CRYSTAL LAKE, IL, UNITED STATES - Oct 4, 2016 - Treatments utilizing regenerative medicine cause our body’s natural healing processes to work both more effectively and rapidly
    Full story
  • TARGET PharmaSolutions Announces the Launch of TARGET-PBC (Primary Biliary Cholangitis)

    Oct 4, 2016, 12:43 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Oct 3, 2016 - TARGET PharmaSolutions, Inc. is pleased to announce the launch of TARGET-PBC (Primary Biliary Cholangitis)
    Full story
  • Biotech PR Needs to Deliver More Signal Less Noise

    Oct 4, 2016, 10:49 AM by Michael Croft
    Forbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.
    Full story
  • Genedata Screener 14 Raises the Bar on Efficiency and Workflow Support

    Oct 4, 2016, 10:14 AM by Michael Croft
    BASEL, N/A, SWITZERLAND - Oct 4, 2016 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Screener® version 14
    Full story
  • «
  • 331
  • 332
  • 333 (current)
  • 334
  • 335
  • 336
  • 337
  • 338
  • 339
  • 340
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy